Detalles de la búsqueda
1.
The age-dependent immunogenicity after two doses of MVC-COV1901 vaccine.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267573
2.
First-in-Human Trial of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine with Adjuvant of Aluminum Hydroxide and CpG 1018
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21254668
3.
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267439
4.
Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blinded, Randomised, Placebo-Controlled Phase 2 Trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261532
Resultados
1 -
4
de 4
1
Próxima >
>>